Diagnostic Hybrids Announces FDA Clearance of D3R FastPoint
Diagnostic Hybrids announces FDA (510k) clearance of its D3 FastPointTM L-DFATM RSV/MPV Identification Kit, which allows for the identification of respiratory syncytial virus and human metapneumovirus from a patients specimen in under 25 minutes.
Read More